DIA-US FDA-ANDA WORKSHOP: Present And Future Perspectives On Generic Drug Life Cycle Management

An Overview of the ANDA Review Process

Sarah Ibrahim, PHARMD, PHD

FDA, United States

Associate Director for Stakeholder and Global Engagement, Office of Generic Drug